Skip to main content
  • Insights Open link menu
    Insights
    • Stories
    • Events
    • Resources
    • News
    • Glossary
  • Sustainability Open link menu
    Sustainability
    • Neuland Foundation
    • Our Approach to Sustainability
    • Climate and Environment
    • Sustainable Supply Chain
    • Our People
    • Supporting the Community
    • Reports Archive
    • Supplemental ESG information
  • Investors Open link menu
    Investors
    • News and Events Open link menu
      News and Events
      • Board Meeting
      • Disclosures to Stock Exchange
      • General Meeting
      • Postal Ballot
      • Corporate Action
      • Credit Rating
    • Financials and Reports Open link menu
      Financials and Reports
      • Quarterly Results
      • Annual Report
      • Subsidiary Financials
      • Annual Return
    • Investor Meetings Open link menu
      Investor Meetings
      • Analyst Meets
      • Investor Presentations
      • Transcripts
      • Investor Call Recordings
    • Corporate Governance Open link menu
      Corporate Governance
      • Committees of the Board
      • Policies and Documents
      • Corporate Governance Reports
    • Disclosures under Regulation 46 of SEBI Listing Regulations
    • Investor Services Open link menu
      Investor Services
      • Shareholding
      • Unpaid and Unclaimed Dividend
      • Share Price
      • Equity and Dividend History
      • IEPF Details
      • Investor Contacts / Grievances
      • TDS Related Information on Dividend
      • Investor Forms and Services
      • Online Dispute Resolution Portal
  • Careers Open link menu
    Careers
    • People
    • Learning at Neuland
    • Careers at Neuland
  • Contact us
Header logo
  • About Us Open link menu
    About Us

    Since inception, at Neuland our purpose has been to build a quality-conscious pharmaceutical company high on integrity. We work with over 500 pharma and biotech organizations, advancing healthcare solutions, to help create a healthier world.

    About Us
    • Our Business
    • Our Brand
    • Our Vision and Values
    • Our History
    • Our Business Model
    • Leadership
    • Our Facilities Open link menu
      Our Facilities
      • R & D Centre
      • Unit I - Bonthapally
      • Unit II - Pashamylaram
      • Unit III - Gaddapotharam
      • Upcoming Peptide Facility
    About us

    close Menu

  • Our Capabilities Open link menu
    Our Capabilities

    Our robust enabling capabilities ensure the seamless execution of our core services and form the backbone of our operations. This guarantees that we consistently deliver high-quality, compliant and innovative solutions to our clients.

    Our Capabilities
    • Chemistry and Reactions
    • Supply Chain Management
    • Quality Control & Assurance
    • Project Management
    • Regulatory CMC Support
    • Intellectual Property
    Our Capabilities

    close Menu

  • Generic APIs Open link menu
    Generic APIs

    With over 4 decades of expertise and a strong focus on innovation, we provide a diverse portfolio of APIs across various therapeutic categories. Our strategic priority is to cater to quality-conscious customers and offer products differentiated by technology.

    Generic APIs
    • API Products
    • Download Brochure
    Product List
    Product List Brochure
    Link

    close Menu

  • CDMO Services Open link menu
    CDMO Services

    At Neuland we prioritize our customer needs, working collaboratively to ensure project success. We provide an end-to-end continuum of customised NCE development services from lab to commercial supply.

    CDMO Services
    • Custom Development Open link menu
      Custom Development
      • Chemistry and Process Development
      • Analytical Development & Validation
      • Process Safety & Engineering Assessment
      • Phase Appropriate Development
    • Custom Manufacturing
    • Peptides Open link menu
      Peptides
      • Process Development
      • Large scale cGMP Manufacturing
      • Analytical R&D
      Peptides
      • Process Development
      • Large scale cGMP Manufacturing
      • Analytical R&D
    CDMO Brochure
    CDMO Brochure
    Link

    close Menu

  • Insights Open link menu
    Insights
    • Stories
    • Events
    • Resources
    • News
  • Sustainability Open link menu
    Sustainability
    • Neuland Foundation
    • Our Approach to Sustainability
    • Climate and Environment
    • Sustainable Supply Chain
    • Our People
    • Supporting the Community
    • Reports Archive
  • Investors Open link menu
    Investors
    • News and Events Open link menu
      News and Events
      • Board Meeting
      • Disclosures to Stock Exchange
      • General Meeting
      • Postal Ballot
      • Corporate Action
      • Credit Rating
    • Financials and Reports Open link menu
      Financials and Reports
      • Quarterly Results
      • Annual Report
      • Subsidiary Financials
      • Annual Return
    • Investor Meetings Open link menu
      Investor Meetings
      • Analyst Meets
      • Investor Presentations
      • Transcripts
      • Investor Call Recordings
    • Corporate Governance Open link menu
      Corporate Governance
      • Committees of the Board
      • Policies and Documents
      • Corporate Governance Reports
    • Disclosures under Regulation 46 of SEBI Listing Regulations
    • Investor Services Open link menu
      Investor Services
      • Shareholding
      • Unpaid and Unclaimed Dividend
      • Share Price
      • Equity and Dividend history
      • IEPF Details
      • Investor Contacts / Grievances
      • TDS Related Information on Dividend
      • Investor Forms and Services
      • Online Dispute Resolution Portal
  • Careers Open link menu
    Careers
    • People
    • Learning at Neuland
    • Careers at Neuland
  • Contact us
  • Please fill out this field

Please ENTER to search

Please fill out this field
Investor Forms and Services
Breadcrumbs
  • Home
  • Investors
  • Investor Services
  • Investor Forms and Services

Investor Forms and Services

Breadcrumbs
  • Home
  • Investors
  • Investor Services
  • Investor Forms and Services
Title Download
Neuland Shareholders Satisfaction Survey - 2026 Click here
100 days Campaign - "Saksham Niveshak" PDF
Form-ISR-1 PDF
Form-ISR-2 PDF
Form-ISR-3 PDF
Form-ISR-4 PDF
Form-ISR-5 PDF
Form-ISR-13 PDF
Form-ISR-14 PDF
  • MailContact Us
Neuland Labs
Quick links
  • About us
  • Our Capabilities
  • Generic APIs
  • CDMO Services
  • Peptide Development
  • Stories
  • Sustainability
  • Investors
  • Careers
  • Glossary
Get in touch

Contact us

Connect with us
  • Terms and Conditions
  • Privacy policy
  • Cookie policy
  • Cookie settings
  • Site Map

© 2024 Neuland Laboratories Ltd. All rights reserved.